Literature DB >> 8946614

Pharmacology of the low-molecular-weight heparins.

J Fareed1, D A Hoppensteadt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8946614

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN： 0094-6176            Impact factor:   4.180


× No keyword cloud information.
  5 in total

1.  Low molecular weight heparins (enoxaparin) in the management of unstable angina: the TIMI studies. Thrombolysis in Myocardial Infarction.

Authors:  E Gurfinkel; B M Scirica
Journal:  Heart       Date:  1999-09       Impact factor: 5.994

2.  Use of unfractionated heparin and a low-molecular-weight heparin following thrombolytic therapy for acute ST-segment elevation myocardial infarction.

Authors:  Xu-Kai Wang; Ye Zhang; Cheng-Ming Yang; Yan Wang; Guang-Yao Liu
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

3.  Low-molecular-weight heparin in the treatment of deep venous thrombosis.

Authors:  K E Hauer
Journal:  West J Med       Date:  1998-10

4.  Effectiveness and safety of bemiparin versus low-molecular weight heparins in orthopaedic surgery.

Authors:  R Ferriols-Lisart; F Ferriols-Lisart; V Jiménez-Torres
Journal:  Pharm World Sci       Date:  2002-06

Review 5.  Low-molecular weight heparin prevents portal vein system thrombosis after splenectomy: a systematic review and meta-analysis.

Authors:  Ming Yang; Jinlong Liu
Journal:  ANZ J Surg       Date:  2020-04-27       Impact factor: 1.872
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.